# Impacts of Nicotinamide Riboside on Functional Capacity and Muscle Physiology in Older Veterans

> **NCT04691986** · NA · ACTIVE_NOT_RECRUITING · sponsor: **VA Office of Research and Development** · enrollment: 74 (actual)

## Conditions studied

- Sarcopenia
- Nicotinamide Adenine Dinucleotide Concentration
- Muscle Quality and NAD+ Content

## Interventions

- **DIETARY_SUPPLEMENT:** Nicotinamide Riboside
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04691986
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-09-01
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-06-30
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2026-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04691986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04691986, "Impacts of Nicotinamide Riboside on Functional Capacity and Muscle Physiology in Older Veterans". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04691986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*